Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
A Study of Florbetapir (18F) in Japanese Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Retrieval of Patient Information After Discontinuation
- Status
- TERMINATED
- Phase
- N/A
A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1
Experimental Study to Validate the "Therapeutic Game" CONEM-BETA
- Status
- COMPLETED
- Phase
- NA
Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
- Status
- COMPLETED
- Phase
- NA
Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
- Status
- WITHDRAWN
- Phase
- NA
" The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study
- Status
- UNKNOWN
- Phase
- NA
Efficacy and Safety of Filgrastim in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Composite MR Neuroimaging Marker for Alzheimer's Disease
- Status
- WITHDRAWN
- Phase
- N/A
Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
- Status
- COMPLETED
- Phase
- PHASE3
Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)
- Status
- COMPLETED
- Phase
- NA
Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults
- Status
- COMPLETED
- Phase
- PHASE1
Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
- Status
- COMPLETED
- Phase
- PHASE1
NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
- Status
- COMPLETED
- Phase
- PHASE2